Steve Berman (lawyer)

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Silvergate Capital (SI) Investors with $1 Milllion+ Losses to Contact Firm’s Attorneys, Expanded Class Period in Securities Fraud Class Action

Retrieved on: 
Monday, January 23, 2023

Moreover, Silvergate did not maintain sufficient liquidity to protect against a bank run.

Key Points: 
  • Moreover, Silvergate did not maintain sufficient liquidity to protect against a bank run.
  • Investors began to learn the truth on Nov. 7, 2022, when Silvergate suddenly and without explanation announced demotion of its Chief Risk Officer.
  • Over the ensuing months, news continued to emerge about Silvergate’s exposure to FTX and Alameda and the company’s lax compliance.
  • If you invested in Silvergate and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

FXLV 2-WEEK DEADLINE ALERT: Hagens Berman Encourages F45 Training Holdings (FXLV) Investors with Losses to Contact Firm’s Attorneys Before Feb. 6th Deadline in Securities Class Action

Retrieved on: 
Monday, January 23, 2023

SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges F45 Training Holdings, Inc. (NYSE: FXLV) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges F45 Training Holdings, Inc. (NYSE: FXLV) investors who suffered significant losses to submit your losses now .
  • According to the complaint, Defendants made false and misleading statements or failed to disclose in the IPO offering documents material adverse facts about F45’s business, operations, and prospects.
  • If you invested in F45 and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding F45 should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

VERU 2-WEEK DEADLINE ALERT: Hagens Berman Encourages Veru Inc. (VERU) Investors with Significant Losses to Contact Firm’s Attorneys Before Feb. 6th Deadline in Securities Fraud Class Action

Retrieved on: 
Monday, January 23, 2023

SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now .
  • VERU’s filings therefore concealed the true risks faced by the Company in gaining approval for its EUA request.
  • Investors learned the truth on Nov. 9, 2022, when Veru announced that the FDA advisory committee (“AdCom”) voted against approving sabizabulin under the agency’s EUA pathway.
  • If you invested in Veru and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

ENVX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

Retrieved on: 
Monday, January 23, 2023

SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Generac Holdings (GNRC) Investors with Significant Losses to Contact Firm’s Attorneys Before Jan. 30th Deadline in Securities Class Action

Retrieved on: 
Monday, January 23, 2023

SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Generac Holdings Inc. (NYSE: GNRC) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Generac Holdings Inc. (NYSE: GNRC) investors who suffered significant losses to submit your losses now .
  • Each of these disclosures caused the price of Generac shares to decline sharply, thereby injuring investors.
  • “We’re focused on investors’ losses and proving Generac cooked its books,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Generac and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Y-mAbs Therapeutics (YMAB) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Filed

Retrieved on: 
Thursday, January 19, 2023

SAN FRANCISCO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) investors who suffered significant losses to submit your losses now .
  • If you invested in Y-mAbs and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Y-mAbs should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.
  • For more information, call Reed Kathrein at 844-916-0895 or email [email protected] .

HAGENS BERMAN, National Trial Attorneys, Encourages Planet Fitness (PLNT) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Thursday, January 19, 2023

SAN FRANCISCO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Planet Fitness, Inc. (NYSE: PLNT) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Planet Fitness, Inc. (NYSE: PLNT) investors who suffered significant losses to submit your losses now .
  • Planet Fitness attributed the success to its making the sign-up process even more seamless and targeted customer acquisition strategy.
  • “We’re focused on investors’ losses and whether Planet Fitness may have misled investors by, among other things, reporting illegally-obtained revenues,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Planet Fitness and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Mercury Systems (MRCY) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Thursday, January 19, 2023

The company primarily blamed material and order delays, in-quarter supply decommits, long lead times for high end semiconductors, and delayed supply in deliveries.

Key Points: 
  • The company primarily blamed material and order delays, in-quarter supply decommits, long lead times for high end semiconductors, and delayed supply in deliveries.
  • “We’re focused on investors’ losses and whether Mercury may have cooked its books,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Mercury Systems and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Mercury Systems should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages UP Fintech Holding (TIGR) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Wednesday, January 18, 2023

SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges UP Fintech Holding Limited (NASDAQ: TIGR) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges UP Fintech Holding Limited (NASDAQ: TIGR) investors who suffered significant losses to submit your losses now .
  • UP Fintech Holding Limited (TIGR) Investigation:
    The investigation focuses on UP Fintech’s statements about the sources and legality of its growth.
  • This news drove the price of UP Fintech American Depositary Receipts sharply lower on Dec. 30, 2022.
  • If you invested in UP Fintech and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

FATE INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Wednesday, January 18, 2023

SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Fate Therapeutics, Inc. (NASDAQ: FATE) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Fate Therapeutics, Inc. (NASDAQ: FATE) investors who suffered significant losses to submit your losses now .
  • “We’re focused on investors’ losses and whether Fate may have misled investors about the strength of- and prospects for- its work with Janssen,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Fate Therapeutics and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Fate Therapeutics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.